26 results
8-K
EX-99.1
RLYB
Rallybio Corporation
10 Apr 24
Entry into a Material Definitive Agreement
4:10pm
disability in those babies who survive. There is currently no approved therapy for the prevention or prenatal treatment of FNAIT.
About Rallybio
8-K
bh5h pmkj
29 Jun 23
Departure of Directors or Certain Officers
7:30am
8-K
EX-99.1
ol68cplnd
28 Sep 22
Regulation FD Disclosure
8:15am
DEF 14A
9il9pnn
25 Apr 22
Definitive proxy
5:03pm
10-K
79llm
15 Mar 22
Annual report
4:31pm
8-K
EX-99.1
dadysb j4
7 Mar 22
MARCH 2022 TAKING A DEVASTATING DISEASE – AND DEVASTATING IT. We’re going there. Corporate Presentation
8:00am
8-K
EX-3.2
03eh5vp0
2 Aug 21
Entry into a Material Definitive Agreement
4:16pm
424B4
c23axag394
30 Jul 21
Prospectus supplement with pricing info
8:28am
S-1/A
EX-10.22
ls5w6q50
22 Jul 21
IPO registration (amended)
4:04pm
S-1/A
EX-3.2
0gukur
22 Jul 21
IPO registration (amended)
4:04pm
S-1/A
EX-10.20
l8l2iqgkb6ifqh pgf6
22 Jul 21
IPO registration (amended)
4:04pm
S-1/A
uipe0xk6t7 v1
22 Jul 21
IPO registration (amended)
4:04pm
S-1/A
EX-10.12
zfy9oznsjj2lzezq
22 Jul 21
IPO registration (amended)
4:04pm
S-1/A
EX-10.21
whwl5wkf z4pijul
22 Jul 21
IPO registration (amended)
4:04pm
S-1
EX-10.1
v9qs2vr
2 Jul 21
IPO registration
4:28pm